N/A Completed N=30 Treatment

Mobile Technology for Blood Pressure Management

Hypertension

Source: ClinicalTrials.gov NCT04841317 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2024

Primary outcomePrimary: Change in Blood Pressure — -14.5; -6.3 mmHg

Summary

The primary objective of this study is to assess the feasibility and effectiveness of a mobile-technology based system that integrates patient-facing and clinician-facing components to assist the management of hypertension.

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Blood Pressure	-14.5; -6.3	—
PRIMARY Participant Survey	5; 6.2; 4.9; 6.2; 5.2; 1.9	—
PRIMARY Physician Survey	5; 5; 2; 2; 5	—

Eligibility Criteria

Inclusion Criteria

18 years or older with an established diagnosis of essential hypertension

Exclusion Criteria

Patients on more than 2 antihypertensives at time of enrollment
Clinical diagnosis of secondary hypertension, that is, hypertension due to a secondary cause, including but not limited to the following:
Renal artery stenosis
Primary hyperaldosteronism
Cushing syndrome
Coarctation of the aorta
Drug-induced hypertension
Pheochromocytoma
Obstructive sleep apnea
Hospitalization for malignant hypertension or severe hypertension (including stroke, cardiac events, acute kidney injury) in the preceding 6 months
Hospitalization for unstable angina or myocardial infarction in the preceding 6 months
Prior diagnosis of heart failure or cardiomyopathy
Stroke or transient ischemic attack within prior 6 months
Prior organ transplantation
Failure to obtain informed consent
Pregnant or currently trying to become pregnant
Patients who are enrolled in other research studies

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04841317). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.